Correlation Between Regen BioPharma and Oxford Cannabinoid

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Oxford Cannabinoid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Oxford Cannabinoid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regen BioPharma and Oxford Cannabinoid Technologies, you can compare the effects of market volatilities on Regen BioPharma and Oxford Cannabinoid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Oxford Cannabinoid. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Oxford Cannabinoid.

Diversification Opportunities for Regen BioPharma and Oxford Cannabinoid

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Regen and Oxford is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Oxford Cannabinoid Technologie in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oxford Cannabinoid and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Oxford Cannabinoid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oxford Cannabinoid has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Oxford Cannabinoid go up and down completely randomly.

Pair Corralation between Regen BioPharma and Oxford Cannabinoid

Assuming the 90 days horizon Regen BioPharma is expected to generate 1.88 times more return on investment than Oxford Cannabinoid. However, Regen BioPharma is 1.88 times more volatile than Oxford Cannabinoid Technologies. It trades about 0.2 of its potential returns per unit of risk. Oxford Cannabinoid Technologies is currently generating about 0.04 per unit of risk. If you would invest  1,445  in Regen BioPharma on September 2, 2024 and sell it today you would lose (1,437) from holding Regen BioPharma or give up 99.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Regen BioPharma  vs.  Oxford Cannabinoid Technologie

 Performance 
       Timeline  
Regen BioPharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.
Oxford Cannabinoid 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oxford Cannabinoid Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Oxford Cannabinoid is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Regen BioPharma and Oxford Cannabinoid Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regen BioPharma and Oxford Cannabinoid

The main advantage of trading using opposite Regen BioPharma and Oxford Cannabinoid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Oxford Cannabinoid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oxford Cannabinoid will offset losses from the drop in Oxford Cannabinoid's long position.
The idea behind Regen BioPharma and Oxford Cannabinoid Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities